touchPODCAST

Thyroid eye disease: An evolving continuum of care

touchPANEL DISCUSSION for touchENDOCRINOLOGY

Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease. 

The experts

• Dr Andrea Kossler, Stanford University School of Medicine, Palo Alto, CA, USA
• Dr Mario Salvi, University of Milan, Milan, Italy
• Dr Edsel Ing, University of Alberta, Edmonton and University of Toronto, Ontario, Canada

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Horizon Therapeutics and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit:

https://touchendocrinologyime.org/thyroid-eye-disease-an-evolving-continuum-of-care/

 

 

Intracranial haemorrhage related to direct oral anticoagulant medications: Latest evidence for reversal strategies

touchTALKS for touchNEUROLOGY

A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition. 

The expert

• Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchneurology.com

Intracranial haemorrhage related to direct oral anticoagulant medications: Latest evidence for reversal strategies

touchTALKS for touchCARDIO

A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition. 

The expert

• Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchCARDIO.com 

Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches

touchFOCUS for touchONCOLOGY

 

Listen to Dr Dana Chase discuss the role of HER2 as a pan-tumour biomarker and the implications for treatment across various cancer types.

The expert

• Dr Dana Chase - UCLA Health, Los Angeles, CA, USA

 

This touchPODCAST is for HCPs only.

 

This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. 

 

For further information visit our website: https://touchoncologyime.org/

 

The path from detection to personalized long-term care for Fabry disease

touchEXPERT OPINIONS for touchENDOCRINOLOGY

Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.

The experts

• Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic
• Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
• Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

www.touchENDOCRINOLOGY.com 

 

The path from detection to personalized long-term care for Fabry disease

touchEXPERT OPINIONS for touchCARDIO

Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.

The experts

• Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic
• Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
• Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

www.touchCARDIO.com 

The path from detection to personalized long-term care for Fabry disease

touchEXPERT OPINIONS for touchNEUROLOGY

Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.

The experts

• Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic
• Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
• Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

www.touchNEUROLOGY.com

Demystifying virology: The link between the HIV life cycle and ART

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES

Listen to leading experts describe the HIV life cycle, the rationale for multidrug antiretroviral therapy (ART) regimens, mechanisms of ART resistance and how to manage it in people living with HIV.

The experts

• Prof. Anne-Mieke Vandamme - Katholieke Universiteit Leuven, Belgium
• Prof. José Arribas - La Paz Hospital, Madrid, Spain
• Prof. Antonella Castagna - Vita-Salute San Raffaele University, Milan, Italy

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is provided by touchIME.

For further information visit our website: 

https://touchinfectiousdiseases.com/education/demystifying-virology-the-link-between-the-hiv-life-cycle-and-art/

 

Knowledge for nurses ADC updates in breast cancer

touchIN CONVERSATION for touchONCOLOGY

Listen to Ms Nikolina Dodlek, an oncology nurse from Croatia, in conversation with Professor Sherko Kümmel, a leading medical oncologist from Germany. They respond to questions submitted by the HCP audience and provide their expert insights on the use of HER2-directed antibody–drug conjugates (ADCs) in the treatment of patients with breast cancer.

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Daiichi Sankyo Europe GmbH and AstraZeneca. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchoncologyime.org/knowledge-for-nurses-adc-updates-in-breast-cancer

Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma

touchPANEL DISCUSSION for touchONCOLOGY 

Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing. 

The experts

• Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
• Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
• Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.

For further information visit: https://touchoncologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma